Tag: Moderna

The U.S. drug regulator gave Moderna Inc clearance to speed up output of its COVID-19 vaccine by letting it fill a single vial with up to 15 doses, with the United States banking on rapid immunisation to stem the spread of the deadly virus.

COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced risk of infection by 80% two weeks or more after the first of two shots, according to data from a real-world U.S. study released on Monday.

The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.

AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company’s shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.

Moderna Inc said on Monday it is proposing filling vials with additional doses of the COVID-19 vaccine to ease a crunch in manufacturing as the company approaches the manufacturing of almost a million doses a day.

Moderna has said it believes its COVID-19 vaccine is effective against new variants of the coronavirus, although it will test a new booster shot aimed at the strain discovered in South Africa after tests showed the antibody response could be reduced.

Moderna Inc said on Tuesday it had received a report from California’s health department that several people at a center in San Diego were treated for possible allergic reactions to its COVID-19 vaccine from a particular batch.

Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its experimental COVID-19 vaccine available globally in the first quarter of 2021.

Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.